Exor to buy 15% shareholding in Philips
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023
Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated